Connect with us

Health

Dr. Steven Batash MD offers custom, non-surgical weight loss solutions with rapid results

mm

Published

5 years ago

on

As one of the world’s leading experts on non-surgical weight loss, Dr. Steven Batash MD believes that shedding unwanted weight is more than just a matter of willpower. Studies show that many efforts to lose weight through diet, restriction, and extreme lifestyle changes will only backfire long term because of their negative mental, emotional and physical effects. When the desired weight-loss is not achieved, oftentimes people blame themselves thinking they cannot simply stick to a diet, when in reality our bodies have a natural inclination to return to their pre-weight-loss set-point. Over time this wreaks havoc on the body, lowering metabolism and increasing appetite. In the end, willpower is a short-term fix for a long-term goal. Dr. Batash’s custom, non-surgical methods for weight-loss are different – they are proven to deliver custom, lasting results that have helped thousands of patients all around the world achieve long-term weight loss, safely and effectively.

Dr. Batash completed his undergraduate at Columbia University and received his medical degree from NYU School of Medicine. He has been practicing medicine in New York City for over 30 years and is among the world’s leading experts in non-surgical weight loss solutions as a board-certified gastroenterologist. Dr. Batash is currently affiliated with the NYU Langone Medical Center, Lenox Hill Hospital, and New York-Presbyterian Hospital. Currently, Batash Medical Weight Loss Centre has two locations in New York. Batash Medical is dedicated to offering patients customized, personal plans for simple and sustained weight loss. Procedures such as Suture Sculpt and Orbera Balloon along with OnTrack Coaching give patients peace of mind knowing they are taken care of every step of the way.

Suture Sculpt endoscopic sleeve gastroplasty is a non-surgical, minimally invasive outpatient procedure that reduces the amount of food the stomach can hold and modifies the signals sent between the stomach and the brain.  A suturing device is inserted endoscopically to reduce the functional volume of the stomach by up to 60% thus giving a sense of fullness when the patient eats smaller portions. Suture Sculpt differs from bariatric surgery in that recovery time is reduced – patients are discharged within a few hours and can return to work within one to two days, though individual recovery times may vary. There are no physical activity restrictions and patients report little to no pain following this procedure.

The Orbera Balloon procedure requires only mild sedation and is performed by placing a soft, deflated silicone balloon endoscopically into the stomach. After the balloon is in place, a syringe is then used to fill the balloon with a sterile saline solution until it becomes the size of a grapefruit. This creates a sense of fullness when patients eat smaller portions by taking up a significant amount of space in the stomach. After 6 months, the balloon is deflated and removed, similar to the placement process. Recovery time is very quick as patients are discharged within a few hours and most can return to work the next day.

Studies show that endoscopic weight loss procedures yield the best results when paired with proper nutrition and exercise. Because of this, Batash Medical offers before, during, and after-care which includes free lifelong OnTrack coaching. OnTrack is a program aimed to maximize the patient’s weight loss success through personalized nutritional counseling and lifestyle coaching.

Batash Medical also offers other services such as Endoscopy, Colonoscopy, and Capsule Endoscopy.

To learn more about the Batash Endoscopic Weight Loss Centre, or if you have questions about their services, please visit www.batashmedical.com.

Related Topics:
mm

Michelle has been a part of the journey ever since Bigtime Daily started. As a strong learner and passionate writer, she contributes her editing skills for the news agency. She also jots down intellectual pieces from categories such as science and health.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

BioLongevity Labs: How Two Biohackers Are Making Longevity Safe for the Mainstream

mm

Published

3 weeks ago

on

February 18, 2026

By

Humans have been looking for ways to extend their lifespan for hundreds of years. Medicine has made impressive strides, but for many, the effects of aging are still painfully real.

Through BioLongevity Labs, biohackers and entrepreneurs Jay Campbell and Josh Felber aim to introduce ordinary people to potentially life-changing compounds called peptides. Campbell and Felber come from very different backgrounds.

Campbell is a five-time international bestselling author and globally recognized leader in the health-optimization space. Felber is a serial entrepreneur who excels at scaling businesses.

For both men, BioLongevity Labs is more than just a business venture — it’s about helping everyday people discover something that just might prolong and improve their lives.

“Your body inevitably changes as the years pile on,” says Campbell. “Your energy drops, and wrinkles start showing up uninvited. Peptides can change everything.”

Many people have probably heard the term “peptide” in passing. Some may know they’re associated with longevity. Most people just don’t have a strong grasp of how they work.

A peptide is a short chain of amino acids, which are the building blocks of proteins. Essentially, peptides are like shorter, simpler proteins. That might sound unremarkable, but the real magic of peptides lies in how they work.

They function as signaling or “messenger” molecules telling the body to perform specific functions. Many peptides function similarly to hormones. A relevant example is GLP-1 (glucagon-like peptide-1) receptor agonists. This class of medications includes semaglutide and tirzepatide, two wildly popular weight-loss drugs.

“These peptides aren’t just another biohacking fad,” Campbell explains. “They enhance insulin secretion and suppress glucagon release to balance blood sugar levels and promote sustainable weight loss”. But what sets GLP-1 receptor agonists apart is their ability to regulate hunger.

Through the reduction of appetite and increased feelings of fullness, it is far easier for dieters to stick to a calorie deficit.” Although GLP-1 receptor agonists are widely prescribed, most peptides aren’t.

Campbell asserts, because many peptides have the potential to cure illnesses by treating the fundamental root cause, they go against America’s “sick care” model of healthcare. They potentially threaten drug companies and their bottom line.

“Peptides are simultaneously a dream come true for mankind and the worst possible nightmare for the pharmaceutical industry,” says Campbell. “It’s not a conspiracy theory. It’s pure economics and psychology in action. People will do whatever it takes to make as much money as possible in a free-market society, even if it means suppressing a superior solution.”

Patients probably aren’t going to be introduced to peptides through the healthcare system. Many discover them on their own. But for the many people who don’t have a solid understanding of how they work molecularly or even what dose to take, there is a risk. That’s precisely what BioLongevity Labs’ co-founders are attempting to address.

Jay Campbell has dedicated his life to educating people about therapeutic peptides and optimized hormones, and along with his partner Josh Felber, they’ve created a company offering filler-free, third-party tested peptides and bioregulators.

Campbell and Felber stress the fact that BioLongevity Labs isn’t meant to be a replacement for traditional medical care. Instead, its products bridge the gap between clinical and extra-clinical care. There’s no magic pill or single solution to solve the problem of aging.

But thanks to the development of specialized peptides, bioregulators, and small molecules, we’re closer than we’ve ever been before.

Continue Reading

Trending